After the video conference ended, Wei Kang was very confident that a reconciliation had been reached, but he still had a sense of unease.
He always felt that the other party was hiding something, secretly preparing a big move.
One thing that puzzled him was why the other party was always willing to settle out of court. Was there some other reason behind it?
If all you want is money, wouldn't it be a better option to sue for compensation, like other companies whose rights have been infringed?
Why do we keep negotiating with the Three Purities Ones outside the court?
Why not just take the huge sum of $2 billion and leave?
Could it be that the other party also needs the market for Three Purities's Thalassemia Gene Drug?
So they're unwilling to clear out the Three Purities Ones early and withdraw completely?
After all, expanding the market and developing and maintaining patients requires a huge amount of resources.
Although Three Purities has tightened the supply of Gene Drug during this period, the appointments and treatments for patients in the early stages have not been delayed and are still proceeding in an orderly manner.
This information, along with previous clinical trial data, can serve as a valuable reference for those who follow.
The saying goes, "Crossing the river by feeling for stones." Since there are stones to feel for, no one will let go of this opportunity to get something for free.
After pondering for a while, Wei Kang finally managed to resolve a bit of his confusion.
However, there was still one thing he didn't understand.
This doesn't seem to make sense. Broad Institute is just a research institution. Although it has a biotechnology company under its name, it doesn't have the capability to develop large-scale clinical drugs.
Unless?
Dry wood meets a raging fire.
Wei Kang suddenly had a thought and remembered something the opposing lawyer had inadvertently mentioned.
"... My client recently reached a collaboration agreement with Pfizer worth a staggering $1.5 billion..."
That's right! It's Pfizer!
Wei Kang was instantly terrified, and a layer of cold sweat broke out on his forehead.
He only thought he was stalling for time, not realizing that the other side was doing the same thing.
If Pfizer and Broad Institute are collaborating to develop Thalassemia Gene Drug, then everything makes sense.
Just like the collaboration between Three Purities and Syngenta, one party provides genomics technology and the other provides clinical medicine technology, creating a powerful alliance.
Most importantly, with the courageous Three Purities as a pioneer paving the way, and by learning step by step, we can definitely develop the same Thalassemia Gene Drug.
What? You're saying this is a generic drug?
However, the patents for Gene Editing Technology are held by the Broad Institute.
Even if the Three Purities have patented their medicine, it won't matter as long as the Great Sealing Technique is applied to them.
A single act of infringement is sufficient to strip a patent of its legality.
Pfizer could make adjustments to the details, reinvent itself, and King's Return as the original drug.
After Three Purities is kicked out, they will directly replace them with new ones, acquire all the developed patient resources, and seize the entire market in one fell swoop.
That's fucking brilliant!
So the market was developed by Three Purities, the patients were treated by Three Purities, and the drugs were developed by Three Purities.
As a result, as soon as a single patent infringement was committed, Three Purities was immediately banned and sent away.
All subsequent gains will be accepted by Pfizer and Broad Institute, and they might even smugly curse the Three Purities Ones as idiots at the celebration banquet.
If he weren't the victim himself, Wei Kang would have applauded the other party's brilliant move.
Although all of this is just speculation and has not been confirmed.
But Wei Kang knew he couldn't keep waiting like this; he had to take the initiative.
Since the other party has such an idea, we cannot let them succeed.
A tough decision is necessary.
"Damn it, let's just withdraw from the Eagle Country market and fight them to the death!"
Wei Kang was furious and made a decision almost instantly.
Just then, the phone rang suddenly.
It turned out to be a call from Tang Que.
The call connected immediately, and before I could even speak, I heard a hearty laugh, along with a noisy background sound, as if someone was shouting.
"Haha, boss, we did it!"
Tang Que's voice was unusually excited as he shouted, as if presenting a treasure. "We've discovered a new Gene Editing protease! Boss, come and see!"
"What? That's great! It's like a pillow being delivered when you're about to fall asleep!"
Call!
Wei Kang's spirits lifted, and he jumped up and ran downstairs to the Gene Laboratory.
******
Meanwhile, Pfizer's Rare Disease division.
A group of company executives and pharmaceutical experts gathered together, all intently staring at the screen of the electron microscope in front of them.
The image above shows the cell culture dish.
Chief Science Officer Dostan, dressed in a white coat, was so excited he was practically dancing with joy.
"Gentlemen, this is a sample from a Thalassemia patient. We have prepared Guide RNA that can specifically bind to the base sequence of the target DNA, combined it with a special CRISPR-Cas9 plastid provided by Broad Institute, and created Thalassemia Gene Drug."
"Then, we injected the drug into the patient's hematopoietic stem cells, and a miracle happened."
"The newly formed Hemoglobin has turned into a normal disc shape, and the Hemoglobin concentration has also increased significantly. We can now begin clinical treatment on the patient."
"Believe me, once the results come out, our pharmaceutical family will gain another powerful member."
A round of enthusiastic applause broke out, and everyone was overjoyed.
However, if Tang Que were here, he would easily have noticed.
The structure of the CRISPR-Cas9 plastid and Guide RNA of this Gene Drug looks incredibly familiar, almost identical to that of Three Purities's Gene Drug.
They are not exactly the same, but rather very similar.
******
Soon, Zheng Feng learned of this good news.
The clinical trial for the first patient was also successfully completed. The patient felt good after taking the medication, and the Hemoglobin level had returned to normal. Apart from a few minor adverse reactions, it can be said to be quite successful.
Next, Pfizer will conduct subsequent Phase I trials.
With the clinical data from Three Purities available beforehand, they followed it without any problems.
"Very good."
Zheng Feng couldn't help but clench his fists and wave them a few times in the air, feeling a sense of relief throughout his body.
The collaboration with Pfizer has finally yielded fruitful results, and the Broad Institute now has its own blockbuster drug.
This is undoubtedly a major boon for the promotion of CRISPR technology.
This is enough to prove that, apart from Three Purities, other companies can also make rapid breakthroughs in this area.
Once the Phase I and Phase II clinical trials are completed, this Gene Drug can immediately go through the fast-track application process and be launched on the market as soon as possible.
He had been eyeing the vast market for Thalassemia for a long time.
There are 350 million people worldwide who carry the thalassemia gene, and the incidence rate in many high-incidence areas is as high as 10% or more, which means tens of millions of potential patients, and hundreds of thousands of severe cases.
If these critically ill patients could all use Pfizer's Gene Drug.
If one costs one million US dollars, and 100,000 critically ill patients can use it, that would be worth hundreds of billions of US dollars.
Even if there are only 10,000 critically ill patients, that's still 10 billion US dollars.
Zheng Feng did the math in his head and was instantly stunned by the number.
He couldn't help but hold his breath, his heart pounding wildly.
My mouth was dry and I was having trouble breathing.
It took him a while to calm down.
The next second, he jumped up and down and dialed his subordinate's number.
"Immediately, right now, notify the people at Three Purities to stop the settlement negotiations, and at the same time, have the lawyers file a patent infringement lawsuit with the court immediately."
As he said this, a smirk appeared on his face, his eyebrows twitched, and he couldn't hide his smugness.
"I bet the expression on that young China tycoon's face was priceless when he heard this news!"